drugset
drugset / Trial / NCT04883736

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

NCT04883736 ↗

Phase 0 Completed 973 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

To demonstrate the therapeutic equivalence and safety of Tretinoin Gel Microsphere, 0.1% (Taro Pharmaceuticals U.S.A, Inc.) and RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% (Valeant) in the treatment of acne vulgaris.

Timeline

Start
2020-08-31
Primary completion
2021-04-16
Completion
2021-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Tretinoin Small molecule 0.1 % Topical

Indications

acne